Mahalakshmi Shankaran

Author

University of California, Berkeley ORCID

Also Known As

Elisheva Shanes, Gordon Smith, M Shankaran, M. Shankaran, Mahalakshmi Shankaran, Mahalakshmi Shubha Shankaran

125

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of California, Berkeley KineMed (United States)University of Cincinnati Medical Center Duke University Duke Medical Center

About

Mahalakshmi Shankaran is an author at University of California, Berkeley specializing in medicine, physiology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.4K
2	Health Sciences	5	5	952
3	Education	1	1	22
4	Natural Sciences	1	1	31
5	Public Health	1	1	29

Mahalakshmi Shankaran

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, Journal of Clinical Investigation Glucose Tracer InfusionMetabolic DisorderPathologyFatty Liver DiseaseInsulin Signaling	2019	669
Strong Relation Between Muscle Mass Determined by D3-creatine Dilution, Physical Performance, and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men Peggy M. Cawthon, Eric Orwoll, Katherine E. Peters, The Journals of Gerontology Series A	2018	207
Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training Rebecca L. Scalzo, Garrett L. Peltonen, Scott E. Binns, The FASEB Journal Muscle FunctionNeuromuscular CoordinationDeuterium OxideKinesiologySport Nutrition	2014	161
A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration Mahalakshmi Shankaran, Gary A. Gudelsky Psychopharmacology NeuropsychologyPsychopharmacologySocial SciencesNeurotoxic RegimenNeuroimmunology	1999	122
Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine Mahalakshmi Shankaran, Bryan K. Yamamoto, Gary A. Gudelsky European Journal of Pharmacology Psychoactive DrugMedicineMonoamine NeurotransmittersPsychopharmacologyNeuropharmacology	1999	106
Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity Max C. Petersen, Gordon I. Smith, Hector H. Palacios, Cell Metabolism	2024	101
Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT Mahalakshmi Shankaran, Bryan K. Yamamoto, Gary A. Gudelsky Synapse	2001	97
Dilution of oral D<sub>3</sub>‐Creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm Mahalakshmi Shankaran, Gregg Czerwieniec, Chancy Fessler, Journal of Cachexia Sarcopenia and Muscle	2018	97
Circulating protein synthesis rates reveal skeletal muscle proteome dynamics Mahalakshmi Shankaran, Chelsea King, Thomas E. Angel, Journal of Clinical Investigation Muscle TissueMuscle FunctionSkeletal Muscle TissueProteasomeCellular Physiology	2015	89
The Effect of Long Term Calorie Restriction on in Vivo Hepatic Proteostatis: A Novel Combination of Dynamic and Quantitative Proteomics John C. Price, Cyrus F. Khambatta, Kelvin W. Li, Molecular & Cellular Proteomics	2012	84

Page 1